27th March 2020 – Antacids
Market research report interprets definition, an investigation of
significant progress in the market. It provides overall industry survey,
product description, wide array of applications, top players, and development
forecast. It enhances understanding about that market along with new business
trends.
The scope of the global Antacids Market
was appreciated at US$ 5.83 billion in 2017. The range is projected to touch
US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the
forecast. This could be due to increase in
geriatric population encountering GERD (Gastroesophageal reflux disease), poor
eating habits causing acidity, and the ill-effects of anti-inflammatory,
non-steroidal drugs.
It’s a known fact that amongst the
elderly populace, there is a recurrence of acidic complications. This comes
across as a challenge for gastroenterologist as well as the primary care
provider. Plus, these patients do suffer from disorders like erosive
esophagitis, esophageal cancer, and Barrett esophagus. The treatment herein
needs an amalgamation of therapies. This is where antacids come into picture.
Request
a Sample Copy @ https://www.millioninsights.com/industry-reports/antacids-market/request-sample
Besides, growth in e-Commerce is
expected to drive demand for antacids via online retailing channels in the
subsequent years. In other words, growing popularity on the part of e-Commerce
coupled with increase in online medicine providers is expected to bolster the
market. At the same time, restraints do exist in the form of intake by young
children. “Gut” journal states that young children displayed obesity symptoms
on intake of antacids. As far as infants are concerned, antacids are a strict
“no-no”. Even during pregnancy antacids should be avoided as chances of
pre-mature birth can’t be ruled out.
The antacids market is segmented on the
basis of drug class, type of formulation, distribution channel, and geography.
By drug class, the segmentation spans proton pump inhibitors, H2 antagonist
(interventional/surgical simulators), and acid neutralizers. By type of
formulation, the antacids industry comprises tablet, liquid, and powder. By
distribution channel, it consists of retail pharmacies, hospital pharmacies,
and the other distribution channels. By geography, the antacid market is
segmented into North America, LATAM, Asia Pacific, Europe, and MEA.
The players contributing to the
antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt
Benckiser Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson,
and Dr. Reddy’s Laboratories Ltd.
Get
in touch
At Million Insights, we work with the
aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
For
More Information, Visit @ https://www.millioninsights.com
No comments:
Post a Comment